MiMedx Group (NASDAQ:MDXG) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 150 percent decrease over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $64.362 million which beat the analyst consensus estimate of $63.460 million by 1.42 percent. This is a 34.73 percent decrease over sales of $98.605 million the same period last year.